Skip to content

CROI: Lower CD4 count on HIV treatment predicts higher risk of cancers, liver, kidney, cardiovascular disease

CROI: Efavirenz-based ART more effective than nevirapine-based ART as first-line therapy in Southern Africa

CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy

CROI: Urgent action needed to avert `catastrophic` drug-resistant TB epidemic

Health Canada issues warning on use of Baraclude alone in HIV/hepatitis B coinfected

Poor infection control, not poor adherence, responsible for vast majority of drug-resistant TB in Chinese study

Anti-herpes treatment reduces HIV levels; treatment or vaccine urged for HIV prevention

Merck announces plans for licensing Atripla widely in developing world

HIV incidence rising in older gay men in Holland, most men recently infected undiagnosed